Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China

PHASE4UnknownINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2015

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

catheter ablation

circumferential pulmonary vein isolation complex fractionated atrial electrograms ablation circumferential pulmonary vein isolation combined left atrial roof ablation circumferential pulmonary vein isolation combined left atrial isthmus ablation circumferential pulmonary vein isolation combined left atrial roof and isthmus ablation circumferential pulmonary vein isolation combined complex fractionated atrial electrograms ablation

DRUG

Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists

Trial Locations (1)

Unknown

RECRUITING

Renmin Hospital of Wuhan University, Wuhan

Sponsors
All Listed Sponsors
collaborator

Capital Medical University

OTHER

collaborator

Peking Union Medical College

OTHER

collaborator

Guangdong Provincial People's Hospital

OTHER

collaborator

Nanjing Medical University

OTHER

collaborator

West China Hospital

OTHER

collaborator

Dalian Medical University

OTHER

collaborator

Shanghai Chest Hospital

OTHER

lead

Wuhan University

OTHER